Skip to main content
Clinical Trials/JPRN-UMIN000027092
JPRN-UMIN000027092
Recruiting
未知

Comprehensive analysis to identify transcriptomic signatures that positively or negatively correlate with clinical outcome of nivolumab monotherapy in patients with non-small cell lung carcinoma - CTSN study

Sendai Kosei Hospital0 sites40 target enrollmentApril 21, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
on-small cell lung cancer
Sponsor
Sendai Kosei Hospital
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sendai Kosei Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Subjects with a condition requiring systemic treatment with either systemic corticosteroids or other immunosuppressive medications within 14 days of first nivolumab administration.

Outcomes

Primary Outcomes

Not specified

Similar Trials